Posted on

What Caught Our Attention in the Investment World? – Week of January 3-6, 2023

By Kuldip K. Ambastha On Thursday, January 5, 2023, the stock of NovoCure Limited (NVCR), an oncology company, rose by +68.5% for the trading day. The LUNAR study has shown that a medical device developed by NovoCure is able to improve, in a statistically significant way, the prospect of survival for people with late-stage lung …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 3-6, 2023”

Posted on

What Caught Our Attention in the Investment World? – Week of October 31-November 4, 2022

By Kuldip K. Ambastha On the trading day of Tuesday, November 1, 2022, Johnson & Johnson (JNJ), a major pharmaceutical and medical product provider, announced plans to acquire Abiomed, Inc. (ABMD), a medical device maker. Due to this development, for that day the stock price of Abiomed rose sharply by +49.9% per share, while the …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 31-November 4, 2022”